review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1085605345 |
P356 | DOI | 10.1007/S10620-017-4604-0 |
P698 | PubMed publication ID | 28551708 |
P2093 | author name string | Pramod Kumar Garg | |
Soumya Jagannath | |||
P2860 | cites work | The pancreatic stellate cell: a star on the rise in pancreatic diseases | Q24676727 |
Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, , and C1 esterase | Q28319746 | ||
Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up | Q33184449 | ||
PTC124 targets genetic disorders caused by nonsense mutations | Q34003720 | ||
Chronic pancreatitis: diagnosis, classification, and new genetic developments | Q34141293 | ||
Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice | Q34178822 | ||
The effect of renin angiotensin system genetic variants in acute pancreatitis | Q34353579 | ||
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. | Q34483772 | ||
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitis | Q34565750 | ||
Chronic pancreatitis: Asia-Pacific consensus report | Q34619449 | ||
Granulocyte colony-stimulating factor reduces fibrosis in a mouse model of chronic pancreatitis | Q34797345 | ||
Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells | Q35045346 | ||
Identification of a microRNA signature in renal fibrosis: role of miR-21. | Q35326035 | ||
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. | Q35558817 | ||
Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. | Q35597994 | ||
Apigenin inhibits pancreatic stellate cell activity in pancreatitis | Q35602697 | ||
Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells | Q35724699 | ||
A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis | Q35760595 | ||
Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis | Q36247659 | ||
Alcohol and high fat induced chronic pancreatitis: TRPV4 antagonist reduces hypersensitivity | Q36349664 | ||
Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle | Q36692979 | ||
Prolonged high fat/alcohol exposure increases TRPV4 and its functional responses in pancreatic stellate cells | Q36837962 | ||
Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study | Q37246186 | ||
Immune cells and immune-based therapy in pancreatitis | Q38202883 | ||
Prevalence and clinical features of chronic pancreatitis in southern India. | Q38889697 | ||
Survey on chronic pancreatitis in the Asia-Pacific region | Q39017919 | ||
Long-term pain relief with optimized medical treatment including antioxidants and step-up interventional therapy in patients with chronic pancreatitis. | Q39174273 | ||
miR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts | Q39226416 | ||
Idiopathic chronic pancreatitis in India: phenotypic characterisation and strong genetic susceptibility due to SPINK1 and CFTR gene mutations | Q39250160 | ||
Spinal cord stimulation for visceral pain from chronic pancreatitis | Q39260729 | ||
Reduction of fibrosis in dibutyltin dichloride-induced chronic pancreatitis using rat umbilical mesenchymal stem cells from Wharton's jelly | Q39327403 | ||
Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis | Q39339586 | ||
Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition | Q40881901 | ||
Inhibitory effects of interferons on pancreatic stellate cell activation | Q40977157 | ||
MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression | Q41412898 | ||
Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells | Q43006117 | ||
Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan | Q44072963 | ||
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats | Q44387837 | ||
Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin | Q44403199 | ||
Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid | Q44541817 | ||
Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention | Q46135728 | ||
Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model | Q46453761 | ||
Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats | Q46465968 | ||
Role of bone marrow-derived cells in experimental chronic pancreatitis | Q46681572 | ||
Curcumin blocks activation of pancreatic stellate cells | Q46809703 | ||
Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells | Q46911143 | ||
Antioxidants for chronic pancreatitis: reasons for disappointing results despite sound principles | Q46940907 | ||
Beneficial effects of preventive oral administration of camostate on cerulein-induced pancreatitis in rats | Q49277134 | ||
Effects of renin-angiotensin system inhibitors on fibrosis in patients with alcoholic chronic pancreatitis. | Q51286851 | ||
Epithelial NEMO/IKKγ limits fibrosis and promotes regeneration during pancreatitis. | Q51612573 | ||
Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. | Q51888889 | ||
Increased central memory T cells in patients with chronic pancreatitis. | Q51992628 | ||
Protective effects of edaravone on experimental chronic pancreatitis induced by dibutyltin dichloride in rats. | Q53112827 | ||
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats. | Q54207407 | ||
Chronic pancreatitis in Mexico City | Q68878426 | ||
Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats | Q69243975 | ||
Copenhagen pancreatitis study. An interim report from a prospective epidemiological multicentre study | Q71017065 | ||
Antifibrotic effect of the herbal medicine Saiko-keishi-to (TJ-10) on chronic pancreatitis in the WBN/Kob rat | Q73347215 | ||
Nationwide epidemiological survey of chronic pancreatitis in Japan | Q73461337 | ||
Nestin expression in pancreatic stellate cells and angiogenic endothelial cells | Q74432676 | ||
Mast cells and pancreatic stellate cells in chronic pancreatitis with differently intensified fibrosis | Q74525573 | ||
Suppressive effect of herbal medicine saikokeishito on acinar cell apoptosis in rat spontaneous chronic pancreatitis | Q80195556 | ||
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan | Q80228447 | ||
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity | Q80975633 | ||
The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression | Q82106573 | ||
Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats | Q83204392 | ||
α-Tocopherol treatment ameliorates chronic pancreatitis in an experimental rat model induced by trinitrobenzene sulfonic acid | Q83395733 | ||
Treatment with pravastatin attenuates progression of chronic pancreatitis in rat | Q83557569 | ||
Resolution of cystic fibrosis-related diabetes with ivacaftor therapy | Q85214760 | ||
Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord | Q85664585 | ||
A phase II trial of human secretin infusion for refractory type B pain in chronic pancreatitis | Q86523607 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1751-1761 | |
P577 | publication date | 2017-05-27 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Novel and Experimental Therapies in Chronic Pancreatitis | |
P478 | volume | 62 |
Q64105887 | Recent advances in the diagnosis and management of chronic pancreatitis | cites work | P2860 |
Search more.